Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus)
Non-Clinical
Genotoxicity
In Vitro
Galloway (2011)
Combustible and Electronic Cigarette Exposures Increase aCE2 activity and SaRS-CoV-2 Spike Binding.
Nonclinical
Genotoxicity
In Vivo
Ghosh (2022)
Increased Risky Choice and Reduced ChRNB2 Expression in adult Male Rats Exposed to Nicotine Vapor.
Nonclinical
Genotoxicity
In Vivo
Giner (2022)
E-Cigarette Vapour Increases aCE2 and TMPRSS2 Expression in a Flavour- and Nicotine-Dependent Manner.
Nonclinical
Genotoxicity
In Vivo
hamon (2022)
In vitro and in silico genetic toxicity screening of flavor compounds and other ingredients in tobacco products with emphasis on ENDS.
Nonclinical
Genotoxicity
In Vitro
hung (2020)
assessment of In Vitro Toxicity/Genotoxicity of ENDS and Combustible Products
Non-Clinical
Genotoxicity
In Vitro
Jordan (2018)
Investigating DNa adduct formation by flavor chemicals and tobacco byproducts in electronic nicotine delivery system (ENDS) using in silico approaches.
Nonclinical
Genotoxicity
In Vitro
Kang (2020)
alterations of Mitochondrial Network by Cigarette Smoking and E-Cigarette Vaping.
Nonclinical
Genotoxicity
In Vitro
Kanithi (2022)
Metabolites of Tobacco- and E-Cigarette-Related Nitrosamines Can Drive Cu2+-Mediated DNa Oxidation.
Nonclinical
Genotoxicity
In Vitro
Kankanamage (2020)
Differential plasma exosomal long non-coding RNas expression profiles and their emerging role in E-cigarette users, cigarette, waterpipe, and dual smokers.
Nonclinical
Genotoxicity
In Vivo
Kaur (2020)